Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial

BACKGROUND: There is a lack of evidence to guide treatment of comorbid depression and anxiety. Preliminary evidence suggests mirtazapine may be effective in treating patients with both depression and anxiety symptoms. METHODS: We undertook a secondary analysis of mirtazapine (MIR): a placebo-control...

Descripción completa

Detalles Bibliográficos
Autores principales: Rifkin-Zybutz, Raphael, MacNeill, Stephanie, Davies, Simon JC, Dickens, Christopher, Campbell, John, Anderson, Ian M, Chew-Graham, Carolyn A, Peters, Tim J, Lewis, Glyn, Wiles, Nicola, Kessler, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708671/
https://www.ncbi.nlm.nih.gov/pubmed/33143538
http://dx.doi.org/10.1177/0269881120965939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708671/
https://www.ncbi.nlm.nih.gov/pubmed/33143538
http://dx.doi.org/10.1177/0269881120965939

Ejemplares similares